Cambridge Investment Research Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-23,552	Closed	-$65K	–	2034
2017 Q2	$65K	Buy	23,552 +1,143	+5%	+$3.16K	﹤0.01%	1874
2017 Q1	$68K	Buy	22,409 +1,143	+5%	+$3.47K	﹤0.01%	1719
2016 Q4	$67K	Buy	21,266 +7,144	+51%	+$22.5K	﹤0.01%	1614
2016 Q3	$48K	Buy	+14,122	New	+$48K	﹤0.01%	1702